EUVIMEDEUVIMED entdecken
Crossref

Identification of FGG as a Biomarker in Early Gastric Cancer via Tissue Proteomics and Clinical Verification

Wujie Chen, Qihua Ye, Biying Zhang, Zhenhua Ma, Hanxiao Tu iD

Journal of Proteome Research · 2024

DOI: 10.1021/acs.jproteome.4c00624 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, 2024. Verfasst von Wujie Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Ningbo No. 2 Hospital, No. 41 Northwest Street Haishu District, Ningbo, Zhejiang 315010, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Biomarkers, Tumor, Proteomics, Fibrinogen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Hwa Mei Research Foundation of Ningbo Second Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early and accurate diagnosis of gastric cancer (GC) is essential for reducing mortality and improving patient well-being. However, methods for the early diagnosis of GC are still lacking. In this study, by isobaric tagging for relative and absolute quantitation (iTRAQ), we identified 336 proteins that overlapped among the upregulated differentially expressed proteins (DEPs) in early gastric cancer (EGC) versus progressive gastric cancer (PGC), upregulated DEPs in EGC versus nongastric cancer (NGC), and nonsignificant proteins in EGC versus NGC. These DEPs were involved primarily in the neutrophil-related immune response. Network analysis of proteins and pathways revealed that fibrinogen α (FGA), β (FGB), and γ (FGG) are candidates for distinguishing EGC. Furthermore, parallel reaction monitoring (PRM), immunohistochemistry (IHC), and Western blot (WB) assays of clinical samples confirmed that, compared with that in PGC and NGC, only FGG was uniquely and significantly upregulated in the gastric mucosa of EGC. Our results demonstrated that FGG in the gastric mucosa could be a novel biomarker to diagnose EGC patients via endoscopy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsBiomarkers, TumorProteomicsFibrinogenHumansGastric MucosaEarly Detection of CancerFemaleMaleUp-RegulationMiddle AgedImmunohistochemistry

Stichwörter der Autor:innen

FGGbiomarkergastric canceriTRAQ

Substanzen

Biomarkers, TumorFibrinogen

Autor:innen und Institutionen

  • Department of Gastroenterology, Ningbo No. 2 Hospital, No. 41 Northwest Street Haishu District, Ningbo, Zhejiang 315010, China.

ORCID-Profile: Hanxiao Tu

Förderung

  • Hwa Mei Research Foundation of Ningbo Second Hospital

Zitieren

APA

Chen, W., Ye, Q., Zhang, B., Ma, Z., & Tu, H. (2024). Identification of FGG as a Biomarker in Early Gastric Cancer via Tissue Proteomics and Clinical Verification. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.4c00624

Vancouver

Chen W, Ye Q, Zhang B, Ma Z, Tu H. Identification of FGG as a Biomarker in Early Gastric Cancer via Tissue Proteomics and Clinical Verification. Journal of Proteome Research. 2024. doi:10.1021/acs.jproteome.4c00624

BibTeX
@article{Chen2024,
  author = {Chen, Wujie and Ye, Qihua and Zhang, Biying and Ma, Zhenhua and Tu, Hanxiao},
  title = {Identification of FGG as a Biomarker in Early Gastric Cancer via Tissue Proteomics and Clinical Verification},
  journal = {Journal of Proteome Research},
  year = {2024},
  doi = {10.1021/acs.jproteome.4c00624}
}
Kostenlos starten →